SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): November 22, 2002
DEPOMED, INC. |
(Exact name of registrant as specified in its charter) |
California |
|
001-13111 |
|
94-3229046 |
(State of Incorporation or Organization) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
1360 OBrien Drive, Menlo Park, California |
|
94025 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrants telephone no., including area code: |
(650) 462-5900 |
|
NOT APPLICABLE |
(Former name or former address, if changed since last report) |
Item 5. Other Events
On November 22, 2002, DepoMed, Inc. (the Company) and Bristol-Myers Squibb Company (Bristol) entered into a Settlement and Release Agreement which provides for the settlement of litigation between the Company and Bristol related to the Companys U.S. Patent No. 6,340,475. The Settlement and Release Agreement is attached hereto as Exhibit 10.1.
Item 7. Financial Statements and Exhibits
Exhibits
10.1 |
Settlement and Release Agreement, dated as of November 22, 2002, between DepoMed, Inc. and Bristol-Myers Squibb Company. |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
DEPOMED, INC. |
|
|
|
/s/John F. Hamilton |
|
John F. Hamilton |
|
Vice President - Finance and |
|
Chief Financial Officer |
Date: December 3, 2002
EXHIBIT INDEX
Exhibit |
|
10.1 |
Settlement and Release Agreement, dated as of November 22, 2002, between DepoMed, Inc. and Bristol-Myers Squibb Company. |